TriangleN-803 + Nivolumab/Ipilimumab (NCT07355205)
N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT07355205). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
Lo que dice el vídeo
Lee la transcripción
This trial is for adults with stage four or recurrent non-small cell lung cancer who have not had treatment for advanced disease.
The idea: give two immunotherapy antibodies, nivolumab and ipilimumab, by vein, and add N-803, a shot under the skin. N-803 is a form of interleukin 15, a signal that helps immune cells grow and stay active. The hope is that it boosts the other two drugs.
The study looks at safety and how well it works.
This phase 1 and 2 study plans 26 patients. At Washington University School of Medicine in St. Louis, Giordano Cittolin Santos leads it.
Public record; not medical advice.
¿Ya estás en un ensayo?
Se convierte en un proyecto que hay que manejar: citas, estudios de imagen, análisis, efectos secundarios y papeleo. Triangle lo mantiene organizado en un solo lugar, para ti o para quien te ayuda.
Organizar mi ensayoPrueba gratuita de 7 días, después $9 al mes. Cancela cuando quieras.
Cómo funcionan estos ensayos: qué es de verdad la fase 1 · preguntas frecuentes No es evidencia clínica.